2,205
Participants
Start Date
March 15, 2021
Primary Completion Date
February 28, 2023
Study Completion Date
February 28, 2023
Testing incentive
A small incentive will be paid to the provider each time they perform a malaria rapid diagnostic test.
Conditional artemisinin combination therapy subsidy
An additional discount on WHO-approved quality assured ACTs will be offered to individuals with a positive RDT.
Clinton Health Access Initiative, Lagos
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Clinton Health Access Initiative Inc.
OTHER
Moi University
OTHER
Duke University
OTHER